JAMESTOWN
24.2.2021 16:24:06 CET | Business Wire | Press release
Global real estate and investment company Jamestown today announced it has significantly expanded its global presence and now has more than $1 billion in European assets under management with the acquisition of another two buildings in Amsterdam, and a mandate to manage a portfolio of properties across Europe on behalf of one of its institutional investment partners and co-investors, E.ON Pension Trust. This latest news about its European portfolio comes on the heels of Jamestown’s recent purchase of three office buildings in Cologne, Germany, and just over a year after purchasing the iconic Groot Handelsgebouw in Rotterdam, one of the largest mixed-use buildings in the Netherlands, which currently houses more than 450 businesses.
“After entering the European market just over a year ago, Jamestown has grown its platform with $1 billion in assets under management and a knowledgeable real estate team headquartered in Cologne, Germany and offices in Amsterdam, London, and Madrid,” said Jamestown president Michael Phillips. “We continue to see many opportunities for future growth. Our vertically integrated team structure is at the root of our value-add asset management strategy enabling us to create innovative spaces while simultaneously preserving cities’ industrial pasts. As our European footprint expands, we will continue to focus on sustainable, adaptive reuse projects that bring new life to local communities.”
Jamestown’s newly acquired Dutch assets are in Amsterdam’s up-and-coming Schinkel neighborhood and include the historic A-Factorij, previously owned by E.ON Pension Trust and home to one of Jamestown’s European offices, and Helicopterstraat, a property previously owned by Gerose and comprised of four buildings on the adjoining Helicopterstraat, Vliegtuigstraat, and Valschermkade. The properties were acquired in partnership with E.ON Pension Trust and the RAG-Stiftung. E.ON Pension Trust made the decision to include A-Factorij in the co-investment given their belief in the long-term potential of the neighborhood, and that future opportunities in the neighborhood with the newly acquired properties are better acted on as co-investors.
In addition, Jamestown will provide asset management services for a portfolio of properties owned by E.ON Pension Trust in Italy, the Netherlands, Portugal, Spain, and the UK. The properties Jamestown will manage include a mix of shopping centers, office buildings, and mixed-use developments.
“We have known Jamestown for a long time and they have been a great partner to us in the US,” said Udo Schaffer, Vice President, Head of Real Estate, E.ON SE. “Jamestown is one of our preferred global partners given their active approach to asset management and focus on creative and out-of-the-box thinking. After several co-investments with Jamestown in Europe, we now look forward to working with them on the E.ON Pension Trust Separate Account Portfolio.”
A-Factorij (Pilotenstraat 35-45), a 128,177 square foot / 11,908 square meter former bicycle factory was originally built in 1955 and converted into a creative office space in 2002. Jamestown has been involved in management of the property since 2018. Adjacent to A-Factorij is Helicopterstraat, a 67,102 square foot / 6,234 square meter commercial property comprising four interconnected offices and industrial space, with a showroom and gym on the ground floor. The Schinkel district is transforming from industrial and loft offices to a true mixed-use community with a residential focus. The Amsterdam municipality plans to turn the 247-acre neighborhood into a vibrant, innovative, and sustainable district with international allure.
Gerose was represented by Appelhoven Real Estate Advisors in this off-market transaction.
Van Ooijen Accountants & Tax Advisors (Paul van der Aar and Adriaan Daniels) were the legal & tax advisors of the seller, together with HMK Notarissen. Greenberg Traurig represented Jamestown.
“This area of Amsterdam has generated a lot of interest from institutional and private investors from around the world,” said Stijn Uijthoven of Appelhoven Real Estate Advisors. “The properties Jamestown has acquired from Gerose Vastgoed were designed to be flexible and sustainable, and responsive to the changing neighborhood. It was a pleasure to work with Jamestown on this transaction and I look forward to seeing the evolution of the properties and the larger community in the coming years.”
Jamestown has a long-standing commitment to securing a better future for its tenants, residents, visitors, and investors by creating spaces that are sustainable, healthy, and inclusive. In 2020, after achieving its goal to reduce energy and greenhouse gas (GHG) emissions by 20 percent four years ahead of schedule, Jamestown committed to reducing its GHG emissions once again by committing to achieve net zero operational carbon by 2050. Jamestown also joined the ranks of other forward-thinking global organizations and 193 countries, and has adopted the United Nations Sustainable Development Goals into its corporate sustainability strategy.
For high-resolution images of A-Factorij and Helicopterstraat, please click here .
About Jamestown
Jamestown is a design-focused real estate investment and management company with a 37-year track record and a clear mission: to transform spaces into innovation hubs and community centers. Jamestown employs more than 400 people worldwide with headquarters in Atlanta, Georgia, and Cologne, Germany, and offices in Amsterdam, Bogotá, Boston, London, Los Angeles, Madrid, New York, and San Francisco. The company is well-known in the industry for its market discipline. Since its founding in 1983, Jamestown has executed transactions in excess of $35 billion, and as of December 31, 2020, the company has assets under management of $12.1 billion. Current and previous iconic projects include Chelsea Market in New York City, Industry City in Brooklyn, Ponce City Market in Atlanta, Ghirardelli Square in San Francisco, and the Innovation and Design Building in Boston. In addition to its portfolio in key markets throughout the U.S., Jamestown continues to expand its investment footprint to South America and Europe.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210224005702/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release
In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release
- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release
Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
